🇺🇸 FDA

Company profile · Sponsor

Novo

Novo mesto

E078E08 · EMA pharma NOVO MESTO, SI
Pipeline
10
Drugs
0
Patents
0

Quick answer

Novo (E078E08) is a pharma company. headquartered in NOVO MESTO, SI. listed on EMA. NovaPharmaNews links 10 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker E078E08
Exchange EMA
Company type pharma
Headquarters NOVO MESTO, SI

Pipeline (10)

Search pipeline →

  1. ADRENALINE AGUETTANT 1 mg/ml, solution injectable en ampoule

    Novo

    Cardiorespiratory arrest at birth in full-term newborns

    phase 3 small molecule active

    1 trial

  2. TEMOZOLOMIDE , KEYTRUDA 25 mg/mL concentrate for solution for infusion, saline solution for infusion

    Novo

    Newly diagnosed Glioblastoma

    phase 3 small molecule active

    1 trial

  3. Tecentriq 840 mg concentrate for solution for infusion

    Novo

    Metastatic pancreatic ductal adenocarcinoma (mPDAC)

    phase 3 small molecule active

    1 trial

  4. UVEDOSE 100 000 UI, solution buvable en ampoule

    Novo

    Thyroidectomy is a common operation. Transient postoperative hypocalcemia is the main complication, resulting in clinical discomfort for patients, longer hospital stays and increased perioperative cost. Cholecalciferol is used to supplement vitamin D deficiency. We suppose that systematic pre-operative supplementation with cholecalciferol would allow a faster and more appropriate response to post-operative hypocalcemia

    phase 3 small molecule active

    1 trial

  5. Matched Placebo

    Novo

    Mechanical allodynia

    phase 2 small molecule active

    1 trial

  6. Product

    Novo

    Women with an indication for IVF/ICSI

    phase 2 small molecule active

    1 trial

  7. To evaluate the pharmacokinetics and safety of nolasiban

    Novo

    not applicable (submitted trial is a pharmacokinetic study in healthy subjects)

    phase 1 other active

    1 trial

  8. Paracetamol Biofarm, 500 mg, tabletki, Placebo - Nalgesin forte, Nalgesin Forte, 550 mg, tabletki powlekane

    Novo

    Knee osteoarthritis

    approved small molecule active

    1 trial

  9. Sorvasta 20 mg filmsko obložene tablete, Sorvitimb 20 mg/10 mg filmsko obložene tablete, Sorvasta 10 mg filmsko obložene tablete, Sorvasta 40 mg filmsko obložene tablete, Sorvitimb 40 mg/10 mg filmsko obložene tablete

    Novo

    Hyperlipidaemia

    approved small molecule active

    1 trial

  10. Telmisartan/Amlodipine/Hydrochlorothiazide, Teldipin, 80 mg + 5 mg, tabletki, Telmisartan/Amlodipine/Hydrochlorothiazide, Tamloset 40 mg/5 mg tabletta, Tamloset 80 mg/10 mg tabletta, Telassmo 80 mg/10 mg tablete, Tamloset 80 mg/5 mg tabletta, Teldipin, 80 mg + 10 mg, tabletki, Telassmo 40 mg/5 mg tablete, Telmisartan/Amlodipine/Hydrochlorothiazide, Teldipin, 40 mg + 5 mg, tabletki, Telassmo 80 mg/5 mg tablete

    Novo

    Arterial hypertension

    approved small molecule active

    1 trial

Frequently asked questions

What is Novo?

Novo (E078E08) is a pharma company. headquartered in NOVO MESTO, SI. listed on EMA. NovaPharmaNews links 10 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Novo sponsor?

We track 10 ClinicalTrials.gov-linked programs for Novo, including ADRENALINE AGUETTANT 1 mg/ml, solution injectable en ampoule and 9 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Novo company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.